Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8


TNFRSF13C (BAFFR) positive blasts persist after early treatment and at relapse in childhood B-cell precursor acute lymphoblastic leukaemia.

Fazio G, Turazzi N, Cazzaniga V, Kreuzaler M, Maglia O, Magnani CF, Biagi E, Rolink A, Biondi A, Cazzaniga G.

Br J Haematol. 2017 Jun 1. doi: 10.1111/bjh.14794. [Epub ahead of print] No abstract available.


Replicating viral vector platform exploits alarmin signals for potent CD8+ T cell-mediated tumour immunotherapy.

Kallert SM, Darbre S, Bonilla WV, Kreutzfeldt M, Page N, Müller P, Kreuzaler M, Lu M, Favre S, Kreppel F, Löhning M, Luther SA, Zippelius A, Merkler D, Pinschewer DD.

Nat Commun. 2017 May 26;8:15327. doi: 10.1038/ncomms15327.


Flt3 Ligand Regulates the Development of Innate Lymphoid Cells in Fetal and Adult Mice.

Baerenwaldt A, von Burg N, Kreuzaler M, Sitte S, Horvath E, Peter A, Voehringer D, Rolink AG, Finke D.

J Immunol. 2016 Mar 15;196(6):2561-71. doi: 10.4049/jimmunol.1501380. Epub 2016 Feb 5.


Trastuzumab emtansine (T-DM1) renders HER2+ breast cancer highly susceptible to CTLA-4/PD-1 blockade.

Müller P, Kreuzaler M, Khan T, Thommen DS, Martin K, Glatz K, Savic S, Harbeck N, Nitz U, Gluz O, von Bergwelt-Baildon M, Kreipe H, Reddy S, Christgen M, Zippelius A.

Sci Transl Med. 2015 Nov 25;7(315):315ra188. doi: 10.1126/scitranslmed.aac4925.


Reconstitution of the peripheral B lymphocyte compartment in patients with ANCA-associated vasculitides treated with rituximab for relapsing or refractory disease.

Venhoff N, Niessen L, Kreuzaler M, Rolink AG, Hässler F, Rizzi M, Voll RE, Thiel J.

Autoimmunity. 2014 Sep;47(6):401-8. doi: 10.3109/08916934.2014.914174. Epub 2014 May 6.


The amount of self-antigen determines the effector function of murine T cells escaping negative selection.

Swee LK, Nusser A, Curti M, Kreuzaler M, Rolink H, Terracciano L, Melchers F, Andersson J, Rolink A.

Eur J Immunol. 2014 May;44(5):1299-312. doi: 10.1002/eji.201343840. Epub 2014 Mar 7.


In vivo evidence for an instructive role of fms-like tyrosine kinase-3 (FLT3) ligand in hematopoietic development.

Tsapogas P, Swee LK, Nusser A, Nuber N, Kreuzaler M, Capoferri G, Rolink H, Ceredig R, Rolink A.

Haematologica. 2014 Apr;99(4):638-46. doi: 10.3324/haematol.2013.089482. Epub 2014 Jan 24.


Soluble BAFF levels inversely correlate with peripheral B cell numbers and the expression of BAFF receptors.

Kreuzaler M, Rauch M, Salzer U, Birmelin J, Rizzi M, Grimbacher B, Plebani A, Lougaris V, Quinti I, Thon V, Litzman J, Schlesier M, Warnatz K, Thiel J, Rolink AG, Eibel H.

J Immunol. 2012 Jan 1;188(1):497-503. doi: 10.4049/jimmunol.1102321. Epub 2011 Nov 28.

Supplemental Content

Loading ...
Support Center